DARIOHEALTH CORP (DRIO)
NASDAQHealth CareMedical - SpecialtiesSnapshot 2026-11-04
$2.73-8.25%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - SpecialtiesSnapshot 2026-11-04
QuarterlyIQ Insights · DRIO
Next print, the company's guidance track record, and the earnings events we've seen in the last few years.
Likelihood the company beats analyst consensus on its next print. Read from its own beat history plus how sector peers have been reporting. Not a price-direction call: a serial beater often has the beat already priced in.
Prints it beat consensus, recent quarters.
Indicative, not a guarantee. Base rate ~71%.
Industry peers that beat since this name last reported.
Management's most recent EPS guidance action.
expected = 0.35*own_median(8.7) + peer(0.2*0) + term(0.0) → 3.04% (capped ±15.0)
in 7 days
Average absolute move on past earnings days.
Annualized: recent baseline volatility.
Of the last 0 guided quarters.
Actual vs. guided EPS, signed.
Excess return vs. sector ETF, day after print.
Earnings prints and pre-announcements detected in the SEC filing stream.
Results of Operations and Financial Condition. On July 24, 2023, DarioHealth Corp. (the Company") issued a press release which provided certain preliminary unaudited results of operations for the second quarter ended June 30, 2023, based on currently available information. The preliminary unaudited results presented reflect the Company’s estimates based solely upon information available, and the Company’s final results could differ from these estimates due to the completion of the Company’s f…
Quarterly EPS and revenue actuals vs. consensus across the last eight quarters (including beat/miss size and the forward consensus heading into the next print) are on the way.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Results of Operation and Financial Condition. On February 6, 2023, DarioHealth Corp. (the “Company”) issued a press released which provided certain preliminary results of operations for the quarter and fiscal year ended December 31, 2022 based on currently available information. The preliminary results presented reflect the Company’s estimates based solely upon information available, and the Company’s final results could differ from these estimates due to the completion of the Company’s finan…
Results of Operations and Financial Condition. On August 15, 2022, DarioHealth Corp. (the “Company”) issued a press release providing selected financial information for the three and six months ended June 30, 2022. On August 15, 2022, the Company posted to its website a presentation (the “Presentation”) containing its financial results for the quarter ended June 30, 2022. Copies of the press release and Presentation are furnished with this Report on Form 8-K as Exhibits 99.1 and 99.2, respect…
of this Current Report on Form 8-K and Exhibits 99.1 and 99.2 shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, or otherwise subject to the liabilities of that section, unless the Company specifically states that the information is to be considered “filed” under the Exchange Act or specifically incorporates it by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act. In the…
Results of Operations and Financial Condition On August 16, 2021, DarioHealth Corp. (the “Company”) issued a press release announcing the Company’s financial and operating results and recent highlights for the quarter and six months ended June 30, 2021. A copy of that press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K that is furnished pursuant to this